Evaluation of a new antiarrhythmic drug.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002219:Carbamates / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D002302:Cardiac Output / Q000187:drug effects; D002415:Cats; D003864:Depression, Chemical; D004341:Drug Evaluation; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D009325:Nausea / Q000139:chemically induced; D010292:Paresthesia / Q000139:chemically induced; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013268:Stimulation, Chemical; D013610:Tachycardia / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents; D002219:Carbamates; D000644:Quaternary Ammonium Compounds